Current role
Drug Manufacturers - Specialty & Generic · Healthcare
COO, Board Member
2024-06-03–present
Mary Ziping Luo
Equibles does not estimate personal net worth.
Get an email with a short summary when Amphastar Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMPH alertsAbout Mary Ziping Luo
Mary Ziping Luo is recorded as Board Member at Amphastar Pharmaceuticals, Inc. (AMPH) since June 3, 2024 and COO at Amphastar Pharmaceuticals, Inc. (AMPH). The newest filing on record that lists Mary Ziping Luo as COO at Amphastar Pharmaceuticals, Inc. (AMPH) is dated April 15, 2020. Amphastar Pharmaceuticals, Inc. reported in an 8-K filed June 4, 2024 that Mary Ziping Luo was appointed Class II director, effective June 3, 2024. The proxy statement of Amphastar Pharmaceuticals, Inc. reports total compensation of $2,976,100 for Mary Ziping Luo in fiscal 2019, including a base salary of $731,679. Disclosed compensation is on record for 3 fiscal years. Amphastar Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amphastar Pharmaceuticals, Inc. includes Jack Yongfeng Zhang (CEO and Board Member), William J. Peters (CFO and Board Member), William Peters (CFO) and 7 others.
“Each director nominee was duly elected to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified.”
Affiliation history
-
Current
2024-06-03–present
-
Current
Start not stated–present
Last confirmed April 15, 2020
Company network
Leadership on record at Amphastar Pharmaceuticals, Inc.
- Jack Yongfeng Zhang CEO, Board Member
- William J. Peters CFO, Board Member
- William Peters CFO
- Jason B. Shandell General Counsel
- Anthony Pierce Board Member
- David Gaugh Board Member
- Gayle Deflin Board Member
- Howard Lee Board Member
- Jacob Liawatidewi Board Member
- Michael A. Zasloff Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Amphastar Pharmaceuticals, Inc. (AMPH) | Chief Operating Officer, Chief Scientist and Chairman | $731,679 | $2,976,100 |
| 2018 | Amphastar Pharmaceuticals, Inc. (AMPH) | Chief Operating Officer, Chief Scientist and Chairman | $907,857 | $3,033,533 |
| 2017 | Amphastar Pharmaceuticals, Inc. (AMPH) | Chief Operating Officer, Chief Scientist and Chairman | $718,001 | $2,956,007 |